745. Combination Treatment of Liposomal Amphotericin B and Isavuconazole is Synergistic in Treating Experimental Mucormycosis

BACKGROUND: Mucormycosis is a life-threatening infection that predominantly occurs in immunocompromised hosts. Liposomal amphotericin B (L-AMB) and isavuconazole (ISAV) are commonly used antifungal drugs to treat mucormycosis. However, the efficacy of combination therapy of L-AMB + ISAV compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebremariam, Teclegiorgis, Gu, Yiyou, Singh, Shakti, Kitt, Therese, Ibrahim, Ashraf S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777982/
http://dx.doi.org/10.1093/ofid/ofaa439.935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777982/
http://dx.doi.org/10.1093/ofid/ofaa439.935

Ejemplares similares